Pelthos Therapeutics Inc.
PTHS
$25.38
$0.240.96%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -370.83% | -75.28% | -2.12% | -13.66% | 4.32% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -99.94% | 74.84% | 23.78% | 631.73% | -- |
| Total Other Non-Cash Items | 1,077.92% | -14.88% | -8.41% | 243.30% | -66.34% |
| Change in Net Operating Assets | -307.67% | 220.84% | 16.22% | -51.94% | 182.48% |
| Cash from Operations | -3,312.82% | 29.27% | 5.70% | -277.21% | 93.98% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -81.87% | 50.00% | 262.55% | 82.86% | -156.53% |
| Total Debt Repaid | -- | -- | -- | 100.00% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 200.67% | -- |
| Cash from Financing | 7,017.87% | 50.00% | 451.12% | 92.67% | -161.24% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 19,786.96% | 81.13% | 48.47% | 35.50% | 15.78% |